Ge
Generate Bio
Cambridge MAFounded 2018100 employees
Private CapbiotechPrivateOncology
Platform: GenAI Protein
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Ivocilimab | GEN-9643 | NDA/BLA | 2 | VEGF | AsthmaObesity | ||
| GEN-3979 | GEN-3979 | Phase 1 | 2 | FXIa | IPF | ||
| Niralemzoparlimab | GEN-3650 | Phase 2/3 | 2 | SOS1 | HNSCCHemophilia A |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)